MRI super-resolution in ten sampling steps using a diffusion bridge model

Objective. MRI provides excellent soft-tissue contrast, but long acquisition times can cause patient discomfort and lead to motion artifacts, forcing a trade-off between spatial resolution and scan time. Diffusion-based super-resolution (SR) reconstructs high-resolution (HR) images from low-resolution (LR) inputs, but typically needs many sampling steps and initializes from a Gaussian prior ill-suited to image restoration. We developed an efficient diffusion framework that reconstructs HR MRI directly from LR data. Approach. We propose super-resolution diffusion bridge model (SR-DBM), a super-resolution diffusion bridge model that casts SR as a stochastic transport between the LR and HR image distributions. Through a Doob's h-transform of a mean-reverting stochastic differential equation, SR-DBM pins the process to the paired HR and LR images at its endpoints, initializing reconstruction from the measured anatomy rather than from Gaussian noise. The HR image is recovered by a deterministic reverse trajectory in which a network predicts the clean image at each of only ten sampling steps. We evaluated SR-DBM on ultra-high-field 7T brain T1 MP2RAGE maps and pelvic T2-weighted prostate images against nine comparison methods using PSNR, SSIM, GMSD, and LPIPS. Main results. SR-DBM attained the highest PSNR and SSIM and the lowest GMSD on both datasets (brain: 27.66+-1.52 dB, 0.96+-0.02, 7.96+-1.86$; prostate: 27.87+-2.29 dB, 0.80+-0.05, 8.38+- 1.44), with statistically significant gains over every comparison method (two-sided Wilcoxon signed-rank test with Holm correction, p<0.05). The strongest baseline, SR-EMamba, ranked second. Qualitatively, SR-DBM produced the smallest residual errors and best preserved fine structures and lesions.

Evaluating GPT-5 as a Multimodal Clinical Reasoner: A Landscape Commentary

The transition from task-specific artificial intelligence toward general-purpose foundation models raises fundamental questions about their capacity to support the integrated reasoning required in clinical medicine, where diagnosis demands synthesis of ambiguous patient narratives, laboratory data, and multimodal imaging. This landscape commentary provides the first controlled, cross-sectional evaluation of the GPT-5 family (GPT-5, GPT-5 Mini, GPT-5 Nano) against its predecessor GPT-4o across a diverse spectrum of clinically grounded tasks, including medical education examinations, text-based reasoning benchmarks, and visual question-answering in neuroradiology, digital pathology, and mammography using a standardized zero-shot chain-of-thought protocol. GPT-5 demonstrated substantial gains in expert-level textual reasoning, with absolute improvements exceeding 25 percentage-points on MedXpertQA. When tasked with multimodal synthesis, GPT-5 effectively leveraged this enhanced reasoning capacity to ground uncertain clinical narratives in concrete imaging evidence, achieving state-of-the-art or competitive performance across most VQA benchmarks and outperforming GPT-4o by margins of 10-40% in mammography tasks requiring fine-grained lesion characterization. However, performance remained moderate in neuroradiology (44% macro-average accuracy) and lagged behind domain-specific models in mammography, where specialized systems exceed 80% accuracy compared to GPT-5's 52-64%. These findings indicate that while GPT-5 represents a meaningful advance toward integrated multimodal clinical reasoning, mirroring the clinician's cognitive process of biasing uncertain information with objective findings, generalist models are not yet substitutes for purpose-built systems in highly specialized, perception-critical tasks.